(Bloomberg) -- When tiny ChemoCentryx won US approval for a pill to treat a rare blood vessel disorder in 2021, executives touted it as a major advance. The next year, Amgen Inc. paid $3.7 billion to ...

An attacker broke into competitive-intelligence vendor Klue, stole OAuth tokens its customers use to connect to Salesforce and other platforms, and accessed data across multiple customer environments ...

Swami Sivasubramanian, AWS VP of agentic AI, shows the Amazon Quick knowledge graph at the AWS Summit in New York. (Screenshot via live stream) Amazon Web Services is announcing a new set of AI agents ...